(2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINE, 95.0%, 100mg

4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide, 95.0%, 25g

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 100mg

Xanthene, 95.0%, 100g

3-(1H-benzimidazol-2-yl)-1,1,1-trifluoroacetone, 95.0%, 5g

ethyl 2-amino-3-(methylcarbamoyl)-4,7-dihydrothieno[2,3-c]pyridine-6(5H)-carboxylate, 95.0%, 500mg

(R)-Pyrrolidine-3-carboxamide hydrochloride, 95.0%, 250mg

N,9,9-Triphenyl-9H-fluoren-2-amine>98.0%(HPLC)(N)5g

tert-Butyl (5-acetyl-6-fluoropyridin-2-yl)carbamate, 97%, 1g

Ethyl 6-oxo-4-(trifluoromethyl)-1,6-dihydropyridazine-3-carboxylate, 97%, 1g

2,4,6-Tribromophenyl Acrylate>98.0%(GC)5g

1,2,3,4,5,6,7,8-Octahydronaphthalene, 98%, 1g

1H-Pyrrolo[3,2-b]pyridine-6-carbaldehyde, 97%, 1g